Biotechnology

Vaxart’s shares drop 50% in weak antibody response to oral vaccine

Pfizer PFE profits in the fourth quarter of 2020 fall short, but revenue exceeds expectations

Covid-19 vaccines leave pregnant women in a dilemma

Covid-19 vaccines leave pregnant women in a dilemma

Amazon, Exxon Mobil, Pfizer, Alphabet and other actions for investors to watch this week

How the UK became the world leader in sequencing the Coronavirus genome

There will be enough Covid vaccines for ‘the entire US adult population by June’, says the doctor

Vacid-19 by J&J: how effective is it and when will it be available?

Vaccine hope driven by data from Novavax and J&J, but fears about new variants remain

Novavax’s stock rises as its Covid-19 vaccine outpaces J&J

The new Covid variants will ‘hit us a lot’, says Dr. Peter Hotez

The new Covid variants will ‘hit us a lot’, says Dr. Peter Hotez